Regional Health Systems Strategist

Bayer; Springfield (MO); On-site; USD 163,000 - 245,000; Full time

Job summary

Bayer is seeking a Regional Account Director to lead strategic engagements with major health systems across multiple states. This role focuses on expanding access for cardiovascular and renal therapies, driving enterprise-level account strategies, and aligning cross-functional teams to maximize patient impact.

The successful candidate will manage a territory with up to 50% travel, build strong relationships with IDNs and health systems, and support a forthcoming novel therapeutic launch, all

Qualifications

• Bachelor’s degree or equivalent required.
• Proven ability to build networks with IDNs and health systems.
• Experience launching new products or indications at account level.
• Excellent facilitation and written/verbal communication skills.
• Willingness to travel up to 50%.
• Ability to meet customer credentialing and safety requirements.

Responsibilities

• Ensure integration and on-label access for CVR portfolio at account level.
• Develop and execute strategic account plans across the enterprise.
• Coordinate cross-functional pull-through to meet objectives.
• Identify key decision makers and clinical/business champions in health systems.
• Build compliant partnerships to expand appropriate use of CVR portfolio.
• Collaborate with cross-functional teams to implement strategic pull-through.

Skills

Relationship building

Account management

Strategic planning

Communication skills

Travel readiness

Credentialing compliance

Education

Bachelor's degree

Advanced degree (Life Sciences/Pharmacy)

Job description

Bayer is seeking a Regional Account Director to lead strategic engagements with major health systems across multiple states. This role focuses on expanding access for cardiovascular and renal therapies, driving enterprise-level account strategies, and aligning cross-functional teams to maximize patient impact.

The successful candidate will manage a territory with up to 50% travel, build strong relationships with IDNs and health systems, and support a forthcoming novel therapeutic launch, all